AJ

Akshay Jagannath Sawant

Active Director Director DIN 09526319
DIN 09526319 First appointment Mar 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshay Jagannath Sawant

Data last updated:

Akshay Jagannath Sawant is a Director at Doczia Pharmaceuticals India Private Limited (since 2022). The company operates in Trading.

DIN 09526319
Primary Designation Director
Industry Trading
First Appointment 03 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Mar 20222022Active

Board colleagues of Akshay Jagannath Sawant

Directorship timeline

Open interactive timeline →
Doczia Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Akshay Jagannath Sawant

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Jagannath Sawant

Akshay Jagannath Sawant currently holds 1 directorship: Doczia Pharmaceuticals India Private Limited (Director, since 03 Mar 2022).

Akshay Jagannath Sawant was first appointed on 03 Mar 2022 as Director at Doczia Pharmaceuticals India Private Limited.

The current boards of Akshay Jagannath Sawant's companies include Abhishek Bunty Thapar (Doczia Pharmaceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available